NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB)

CUSIP: 63937X103

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
9,755,964
Share change
-2,514,402
Total reported value
$1,001,000
Price per share
$0.10
Number of holders
41
Value change
-$1,540,884
Number of buys
8
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP 63937X103?
CUSIP 63937X103 identifies NAVB - NAVIDEA BIOPHARMACEUTICALS I - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) as of Q4 2018

As of 31 Dec 2018, NAVIDEA BIOPHARMACEUTICALS I - COM (NAVB) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,755,964 shares. The largest 10 holders included Vanguard Group Inc, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, NORTHERN TRUST CORP, Allred Capital Management, LLC, WEDBUSH SECURITIES INC, MORGAN STANLEY, Bank of New York Mellon Corp, and CITADEL ADVISORS LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.